Relay Therapeutics (RLAY) Insider Trading & Ownership $3.69 +0.28 (+8.21%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$3.68 0.00 (-0.14%) As of 08/22/2025 06:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Relay Therapeutics (NASDAQ:RLAY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.87%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$3.37M Get RLAY Insider Trade Alerts Want to know when executives and insiders are buying or selling Relay Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RLAY Insider Buying and Selling by Quarter Relay Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/29/2025Brian AdamsInsiderSell18,276$3.68$67,255.68 7/29/2025Donald A BergstromInsiderSell26,701$3.68$98,259.68 7/29/2025Peter RahmerInsiderSell15,724$3.68$57,864.32 7/29/2025Thomas CatinazzoCFOSell18,380$3.68$67,638.40 7/28/2025Brian AdamsInsiderSell1,637$3.74$6,122.38 7/28/2025Donald A BergstromInsiderSell4,069$3.74$15,218.06 7/28/2025Peter RahmerInsiderSell1,359$3.74$5,082.66 7/28/2025Thomas CatinazzoCFOSell1,701$3.74$6,361.74 7/9/2025Sanjiv PatelCEOSell61,379$3.57$219,123.03 4/30/2025Peter RahmerInsiderSell10,739$3.00$32,217.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/30/2025Thomas CatinazzoCFOSell12,943$3.00$38,829.00 4/28/2025Peter RahmerInsiderSell1,364$3.17$4,323.88 4/28/2025Thomas CatinazzoCFOSell2,690$3.17$8,527.30 4/23/2025Sanjiv PatelCEOSell61,422$2.97$182,423.34 3/27/2025Brian AdamsInsiderSell298$2.84$846.32 3/27/2025Thomas CatinazzoCFOSell4,864$2.84$13,813.76 2/13/2025Sanjiv PatelCEOSell75,324$3.70$278,698.80 2/11/2025Sanjiv PatelCEOSell140,182$3.85$539,700.70 1/30/2025Peter RahmerInsiderSell17,250$4.42$76,245.00 1/30/2025Thomas CatinazzoCFOSell20,791$4.42$91,896.22 1/28/2025Peter RahmerInsiderSell1,673$4.63$7,745.99 1/28/2025Thomas CatinazzoCFOSell36,036$4.63$166,846.68 1/22/2025Sanjiv PatelCEOSell125,000$4.80$600,000.00 1/6/2025Peter RahmerInsiderSell16,576$4.45$73,763.20 1/2/2025Peter RahmerInsiderSell32,156$4.15$133,447.40 12/27/2024Brian AdamsInsiderSell299$4.38$1,309.62 12/27/2024Thomas CatinazzoCFOSell4,865$4.42$21,503.30 12/16/2024Sanjiv PatelCEOSell100,000$5.00$500,000.00 10/28/2024Peter RahmerInsiderSell1,621$6.06$9,823.26 10/28/2024Thomas CatinazzoCFOSell6,802$6.06$41,220.12 (Data available from 1/1/2013 forward) RLAY Insider Trading Activity - Frequently Asked Questions Who is on Relay Therapeutics' Insider Roster? The list of insiders at Relay Therapeutics includes Andy Porter, Brian Adams, Donald A Bergstrom, Mark Murcko, Peter Rahmer, Sanjiv Patel, and Thomas Catinazzo. Learn more on insiders at RLAY. What percentage of Relay Therapeutics stock is owned by insiders? 4.87% of Relay Therapeutics stock is owned by insiders. Learn more on RLAY's insider holdings. Which Relay Therapeutics insiders have been selling company stock? The following insiders have sold RLAY shares in the last 24 months: Brian Adams ($75,534.00), Donald A Bergstrom ($128,854.96), Peter Rahmer ($936,634.53), Sanjiv Patel ($2,652,869.29), and Thomas Catinazzo ($656,303.31). How much insider selling is happening at Relay Therapeutics? Insiders have sold a total of 959,513 Relay Therapeutics shares in the last 24 months for a total of $4,450,196.09 sold. Relay Therapeutics Key ExecutivesMr. Alexis A. Borisy A.M. (Age 52)Co-Founder & Independent Chairman Compensation: $92.5kDr. Sanjiv K. Patel M.A. (Age 50)M.B.A., M.D., MBBS, CEO, President & Director Compensation: $1.08MDr. Mark Murcko Ph.D. (Age 64)Co-Founder & Director Compensation: $60kMr. Thomas Catinazzo (Age 47)Chief Financial Officer Compensation: $663.99k5 recent tradesMr. Brian R. Adams J.D. (Age 50)Chief Legal Officer & Secretary Compensation: $627.72kMr. Peter RahmerChief Corporate Development Officer4 recent tradesDr. Donald A. Bergstrom M.D. (Age 52)Ph.D., President of Research & Development Compensation: $1.37M2 recent tradesMs. Dorothee Kern Ph.D.FounderDr. David Elliot Shaw Ph.D. (Age 73)Founder Mr. Matthew P. Jacobson Ph.D.Founder More Insider Trading Tools from MarketBeat Related Companies CNTA Insider Selling TARS Insider Selling IBRX Insider Selling AGIO Insider Selling IDYA Insider Selling DNLI Insider Selling OCUL Insider Selling HRMY Insider Selling SRPT Insider Selling IRON Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (NASDAQ:RLAY) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access